Found 155 matching trials
Combination of Ibrutinib and As2O3 in the Treatment of CLL
PHASE3The purpose of this study is to determine whether the combination of As2O3 ...
Location
Multiple Locations
Oral Arsenic Trioxide for NPM1-mutated AML
PHASE2A prospective open-label phase 2 study will be designed to assess the effic...
Location
The University of Hong Kong
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
PHASE3This is a prospective,controlled and multi-institution trial.The aim is to ...
Location
Ruijin Hospital North
Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS
PHASE2The purpose of this study is to find a new way to treat Acute Myeloid Leuke...
Location
Temple BMT Program at Jeanes Hospital
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
NAThis pilot clinical trial studies the feasibility of choosing treatment bas...
Location
Fred Hutch/University of Washington Cancer Consortium
Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
PHASE2RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, work in di...
Location
UPMC Cancer Centers
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
PHASE2Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Location
National Institutes of Health Clinical Center
Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
PHASE4In this prospective randomized study for patients with newly diagnosed acut...
Location
Department of Hematology
Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
PHASE2This is a Phase II, open-label, non-randomized study to evaluate the safety...
Location
Northwestern University
Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma
PHASE1This pilot clinical trial studies arsenic trioxide in treating patients wit...
Location
Stanford University Medical Center